Menu

5th Annual Conference of Pharmacoepidemiology in Africa opens in Accra

5th Annual Conference Of Pharmacoepidemiology In Africa Opens In Accra 5th Annual Conference of Pharmacoepidemiology in Africa opens in Accra

Mon, 20 Apr 2026 Source: Geroge Owusu, Contributor

Accra is hosting the 5th Annual Conference of Pharmacoepidemiology in Africa from 20–22 April 2026 – a major event focused on making medicines safer for everyone across the continent.

Organised by the Africa Regional Interest Group (AfRIG) of the International Society for Pharmacoepidemiology (ISPE), the three-day conference brings together African and global experts to share real-world, homegrown solutions for monitoring medicine safety, fighting antimicrobial resistance, and promoting the rational use of medicines.

Why Ghana?

Hosting the conference in Ghana highlights the country’s rising role in shaping pharmaceutical policy and medicine safety research. It also strengthens collaboration among pharmacy professionals across Africa.

Programme Highlights

•Keynote address;

•Plenary sessions;

•Scientific symposia, oral and poster presentations;

•Hands-on workshops led by world-renowned researchers; and

•Special opportunities for early-career scientists to learn from and network with leaders in the field.

The conference is a unique platform to build regional and global partnerships and to share impactful research that advances the safe and effective use of medicines, vaccines, and health technologies across Africa.

Collaborators: Ministry of Health (Ghana), University of Ghana, University of Cape Coast, Pharmaceutical Society of Ghana, Pharmacy Council Ghana and Medicines Utilization Research in Africa (MURIA).

What is pharmacoepidemiology?

It’s the science of using population‑based methods to study how medicines, vaccines, and other health products work in real life – including their benefits, risks, and patterns of use.

About ISPE

The International Society for Pharmacoepidemiology (ISPE) has members in 53 countries. It promotes global exchange of scientific knowledge, policy development, and education in pharmacoepidemiology, pharmacovigilance, and therapeutic risk management.

Source: Geroge Owusu, Contributor